Medpace
MEDP
544 hedge funds and large institutions have $7.65B invested in Medpace in 2023 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 201 increasing their positions, 182 reducing their positions, and 34 closing their positions.
182% more first-time investments, than exits
New positions opened: 96 | Existing positions closed: 34
63% more funds holding in top 10
Funds holding in top 10: 8 → 13 (+5)
35% more call options, than puts
Call options by funds: $40.5M | Put options by funds: $29.9M
32% more capital invested
Capital invested by funds: $5.81B → $7.65B (+$1.84B)
11% more funds holding
Funds holding: 488 → 544 (+56)
10% more repeat investments, than reductions
Existing positions increased: 201 | Existing positions reduced: 182
3.31% more ownership
Funds ownership: 78.05% → 81.36% (+3.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$103M |
| 2 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$83.4M |
| 3 |
Man Group
London,
United Kingdom
|
+$46.1M |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$43M |
| 5 |
GC
Giverny Capital
Montreal,
Quebec, Canada
|
+$41.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$52.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$35.4M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$29.1M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$26M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$25.3M |
MEDP Hedge Fund Activity: Q4 2023 in Review
544 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q4 2023, worth a combined $7.65B — up 32% from $5.81B a quarter earlier.
Buyers outnumbered sellers: 96 funds opened new MEDP positions and 34 closed out — a net gain of 62 holders — while 201 added to existing stakes and 182 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $103M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $52.3M.
- 544 institutional investors held Medpace (MEDP) as of Q4 2023, up from 488 in Q3 2023.
- Funds reported $7.65B of Medpace stock for Q4 2023, up 32% quarter-over-quarter.
- 96 funds opened new Medpace positions in Q4 2023 and 34 closed out, a net change of +62 holders.
- The largest Medpace buyer in Q4 2023 was Morgan Stanley, an estimated $103M added.
- The largest Medpace seller in Q4 2023 was Fuller & Thaler Asset Management, an estimated $52.3M sold.
Based on aggregated 13F filings for Q4 2023.